GlobalData’s report assesses the drugs in the Insulin Like Growth Factor I pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Metabotropic Glutamate Receptor 7 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Plasma Kallikrein pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Estrogen Receptor Beta pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Cell Division Cycle 7 Related Protein Kinase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the ...
GlobalData’s report assesses the drugs in the Fibroblast Growth Factor 2 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Alpha N-Acetylglucosaminidase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Toll Like Receptor 3 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Glucagon Like Peptide 2 Receptor pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Bromodomain Testis Specific Protein pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development ...
GlobalData’s report assesses the drugs in the Cathepsin L1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the High Mobility Group Protein B1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback